South Dakota Biotech Association: SAB Delays Location at USD Discovery District to Focus on COVID-19
March 16, 2020
March 16, 2020
SIOUX FALLS, South Dakota, March 16 -- The South Dakota Biotech Association issued the following news release:
SAB Biotherapeutics, a Sioux Falls immunotherapy company rapidly working to develop a therapeutic specific to COVID-19, announced it is delaying its planned development at the USD Discovery District for at least one year.
The company is working on both a test for COVID-19 as well as what could become the first therapeutic developed specifically to treat the dis . . .
SAB Biotherapeutics, a Sioux Falls immunotherapy company rapidly working to develop a therapeutic specific to COVID-19, announced it is delaying its planned development at the USD Discovery District for at least one year.
The company is working on both a test for COVID-19 as well as what could become the first therapeutic developed specifically to treat the dis . . .